SEC ownership of Quantum Biopharma Ltd.

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001771885.

Comparable stake leader

Malone Wealth Ventures LLC

Disclosed value leader

Malone Wealth Ventures LLC

Comparable rows

25/25

Latest evidence

31 Mar 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
25 of 25
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
Malone Wealth Ventures LLC
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
31 Mar 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001771885
Issuer location
Toronto

Ownership snapshot

Top shareholders of Quantum Biopharma Ltd. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Malone Wealth Ventures LLC
Disclosed value leader
Malone Wealth Ventures LLC
Comparable rows
25/25
Latest evidence
31 Mar 2026
13D/G 13F Lead comparable stake: 9.8% 13D/G row: Malone Wealth Ventures LLC Showing 1-8 of 25 holder rows.

Quick read

Malone Wealth Ventures LLC leads the comparable SEC ownership view at 9.8%.

25 of 25 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Malone Wealth Ventures LLC's linked filing trail.
Comparable ownership Top 5
Malone Wealth Ventures LLC 9.8%
AdvisorShares Investments LLC 2.8%
Platform Technology Partners 1.1%
JANE STREET GROUP, LLC 0.82%
CITADEL ADVISORS LLC 0.41%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 25 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Malone Wealth Ventures LLC
13D/G
9.8%
$2,754,262
375,752 shares
-$3,327,659 03 Feb 2026
AdvisorShares Investments LLC
13F
Company
13F
2.8%
$524,495
108,591 shares
31 Mar 2026
Platform Technology Partners
13F
Company
13F
1.1%
$198,590
41,116 shares
31 Mar 2026
JANE STREET GROUP, LLC
13F
Company
13F
0.82%
$152,149
31,501 shares
31 Mar 2026
CITADEL ADVISORS LLC
13F
Company
13F
0.41%
$76,618
15,863 shares
31 Mar 2026
Marex Group plc
13F
Company
13F
0.35%
$65,050
13,468 shares
31 Mar 2026
Virtu Financial LLC
13F
Company
13F
0.32%
$59,000
12,282 shares
31 Mar 2026
Mariner, LLC
13F
Company
13F
0.26%
$48,553
10,059 shares
31 Mar 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 24 Jun 2025.

Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 0 Shares: 0
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

Recent insider transactions for Quantum Biopharma Ltd.

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
No insider transactions were found in the last 12 months for this issuer.
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .